ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

(HealthDay News) — Wildfire smoke exposure over time may increase the risk for heart failure, according to a study published in the July issue of the Journal of the American College of Cardiology.

Delirium most common among those with intracerebral hemorrhage; more severe delirium tied to worse outcomes. (HealthDay News) — More than one in four critically ill patients with stroke experience ...

An elderly man with immunoglobulin G4-related disease (IgG4-RD) with kidney involvement and monoclonal gammopathy was successfully treated with corticosteroid therapy. This case report was published ...

However, incidence rates of vision-threatening diabetic retinopathy, diabetic macular edema, and proliferative diabetic retinopathy have decreased.

(HealthDay News) — Fecal microbiota analysis of pregnant women may provide early identification of those at risk for gestational diabetes, according to a study published online July 1 in Microbiology ...

Investigators studied recent trends in chain ownership, physician ownership, and medical directorship of dialysis facilities in the US.

Cancer patients receiving ICIs may experience more severe toxicity and have a greater risk of death if they have recently used PPIs, data suggest.

The insulin resistance indicators — TyG-WHtR, METS-IR, TyG-BMI, and TyG-WC — were associated with an increased risk for female infertility. Four insulin resistance indicators are associated with ...

Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

Benefits for cancer- and cardiovascular disease-specific mortality vanish with more than low levels of added sugar and saturated fat.

Body fat percentage, waist circumference both significantly associated with 15-year all-cause mortality, heart disease mortality.